Examining to aid CureVac with experimental COVID-19 vaccine: Bayer CEO Ruchika Sharma19 Jan 2021 10:00 AM ISTBerlin: German pharmaceutical giant Bayer is examining whether it can help CureVac to produce its experimental COVID-19 vaccine, its chief executive...
CureVac anticipates to produce COVID-19 vaccine at scale by 2020 end Ruchika Sharma6 Sept 2020 10:00 AM ISTGermany: German biotech company Curevac expects to be able to produce the COVID-19 vaccine it is developing at scale by the end of the year,...
CureVac to raise over Rs 1834 crore IPO in US Ruchika Sharma11 Aug 2020 10:00 AM ISTFrankfurt: CureVac, one of Germany's leading contenders to develop a COVID-19 vaccine, said it aims to raise up to $245 million in an initial...
